|
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
|
3 Months Ended |
|
Mar. 31, 2015
|
Mar. 31, 2014
|
| Cash flows from operating activities: |
|
|
| Net loss |
$ (2,236) |
$ (2,111) |
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| Depreciation and amortization of deferred charges |
23 |
25 |
| Expenses related to shares and options granted to service providers |
0 |
110 |
| Amortization of deferred stock-based compensation related to options granted to employees |
347 |
122 |
| Decrease in accounts receivable and prepaid expenses |
309 |
117 |
| Increase (decrease) in trade payables |
(620) |
98 |
| Increase in other accounts payable and accrued expenses |
233 |
177 |
| Revaluation of warrants |
7 |
1,071 |
| Total net cash used in operating activities |
(1,937) |
(391) |
| Cash flows from investing activities: |
|
|
| Purchase of property and equipment |
0 |
(94) |
| Changes in short-term deposit |
(13,565) |
0 |
| Investment in lease deposit |
0 |
9 |
| Total net cash used in investing activities |
(13,565) |
(85) |
| Cash flows from financing activities: |
|
|
| Proceeds from exercise of warrants |
2,348 |
0 |
| Exercise and reissuance of warrants |
12,397 |
0 |
| Total net cash provided by financing activities |
14,745 |
0 |
| Decrease in cash and cash equivalents |
(757) |
(476) |
| Cash and cash equivalents at the beginning of the period |
4,251 |
3,503 |
| Cash and cash equivalents at end of the period |
3,494 |
3,027 |
| Non-cash financing activities: |
|
|
| Exercise of liability classified warrants |
$ 130 |
$ 0 |